BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Bio Special

Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025

As the healthcare landscape continues to evolve, diagnostic capabilities play a pivotal role in shaping the trajectory of patient care. In 2025, a ...

January 01, 2025 | News

Revolutionizing Tomorrow: Top 24 Emerging Biotech Innovations to Watch in 2024

Unveiling the Pioneering Companies Poised to Transform Healthcare 1. QuantumGen Website: quantumgen.com Location: San Francisco, CA, USA Focu...

December 29, 2023 | News

Breakthroughs Unveiled: A Year of Groundbreaking Novel Drug Approvals in 2023

Innovative drugs often mean new treatment options for patients and advances in health care for the American public. When it comes the development of new dr...

December 29, 2023 | News

Revolutionizing Drug Discovery: 15 AI Companies to Watch in 2024

As we step into 2024, let's explore 15 AI companies at the forefront of this transformative journey. Atomwise: Revolutionizing Virtual Screening Atomw...

December 27, 2023 | News

Biotech and Biopharma Industry Trends: What to Watch for in 2024

In a year-round up preview, Dr. Senthil Sockalingam, Head of IQVIA Biotech in Japan-Asia Pacific and Chief Medical Officer of IQVIA Asia Pacific, offers a ...

December 18, 2023 | Opinion | By Dr Senthil Sockalingam, Head, IQVIA Biotech in Japan-Asia Pacific; Chief Medical Officer, IQVIA Asia Pacific

Advancing Lung Cancer Treatment: Insights from Professor Benjamin Solomon on the ALINA Study and the Future of ALK-Positive NSCLC

In an exclusive BioPharma APAC interview, Professor Benjamin Solomon, a distinguished Medical Oncologist at the Peter MacCallum Cancer Centre, Australia, a...

December 18, 2023 | News

Examining Financial Ruin, Advocating for Change, and Fostering Collaboration in Cancer Care Economics Across the Asia Pacific Region

In a recent email interview with BioPharma APAC, Dr. Nirmala Bhoo-Pathy, a distinguished Professor of (Clinical) Epidemiology at the Faculty of Medicine, U...

December 13, 2023 | News

Combatting Cancer Disparities: Addressing Challenges and Expanding Access to Care in Low- and Middle-Income Countries

In an exclusive email interview with BioPharma APAC, Carmen Auste, the CEO of Cancer Warriors Foundation Philippines and Vice President of Cancer Coalition...

December 13, 2023 | News

IQVIA Experts Share Perspectives on Challenges, Opportunities, and the Transformative Role of DCTs in Asia Pacific

In a dynamically evolving landscape of clinical research, the Asia Pacific (APAC) region has emerged as a key player in adopting Decentralized Clinical Tri...

December 13, 2023 | News

Addressing the Dengue Crisis in Southeast Asia: Insights from Prof. Tikki Pangestu and Prof. Lulu Bravo

In this exclusive interview, BioPharma APAC engage with two distinguished experts in the field of infectious diseases and immunization: Prof. Tikki Pangest...

December 04, 2023 | News

Combatting Cancer Misinformation: Insights from Ranjit Kaur, Breast Cancer Advocate and APOA Advisory Board Member

In an exclusive interaction, Ranjit Kaur, Immediate Past President of the Breast Cancer Welfare Association Malaysia and Advisory Board Member of the Asia ...

December 04, 2023 | News

Asia Pacific Oncology Alliance Report Emphasizes Patient Collaboration for Improved Cancer Care

Report highlights fundamental shift in treatment for cancer, from a terminal to a chronic disease that can be treated and managed Expl...

December 04, 2023 | News

Roche's Ying Ying Yeoh Explores the Power of Public-Private Partnerships in Shaping Healthcare's Future in Asia Pacific

Ying Ying Yeoh, a key figure at Roche, shares insights into the transformative impact of public-private partnerships (PPPs) on healthcare i...

November 29, 2023 | News

Is Asia ready to be the next global biotech hub?

As outlined in Cytiva’s 2023 Global Biopharma Resilience Index, economies such as Singapore, South Korea, Japan and Australia, are able to pr...

November 28, 2023 | Opinion | By Prem Mandalapu, Commercial General Manager, ASEAN, Cytiva

Stay Connected